American Capital Advisory, LLC Royalty Pharma PLC Transaction History
American Capital Advisory, LLC
- $181 Billion
- Q4 2024
A detailed history of American Capital Advisory, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, American Capital Advisory, LLC holds 700 shares of RPRX stock, worth $21,959. This represents 0.01% of its overall portfolio holdings.
Number of Shares
700
Previous 700
-0.0%
Holding current value
$21,959
Previous $19.8 Million
9.83%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding RPRX
# of Institutions
433Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.24 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.17 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$722 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$532 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$443 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $13.7B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...